Establishment of a Poliovirus Containment Program and Containment Certification Process for Poliovirus-Essential Facilities, United States 2017–2022
Upon declaration of poliovirus (PV) type 2 eradication in 2015, the World Health Organization (WHO) published PV containment requirements in the Global Action Plan III (GAPIII) for mitigating the risk of a facility-associated release post eradication. In 2018, the 71st World Health Assembly resoluti...
Main Authors: | Christy Ottendorfer, Bryan Shelby, Cecelia A. Sanders, Anna Llewellyn, Christy Myrick, Christye Brown, Suganthi Suppiah, Kortney Gustin, Lia Haynes Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/13/2/116 |
Similar Items
-
Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014
by: Mohammadreza Shaghaghi, et al.
Published: (2016-10-01) -
Vaccine-Derived Polioviruses, Central African Republic, 2019
by: Marie-Line Joffret, et al.
Published: (2021-02-01) -
The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases
by: Kouichi Kitamura, et al.
Published: (2021-07-01) -
Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
by: T. Jacob John, et al.
Published: (2022-11-01) -
Seroprevalence of poliovirus antibodies in the Kansas City metropolitan area, 2012–2013
by: Gregory S. Wallace, et al.
Published: (2017-04-01)